HALO.NE - Halo Labs Inc.

NEO - NEO Real Time Price. Currency in CAD
0.1050
0.0000 (0.00%)
As of 11:57AM EDT. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.1050
Open0.1050
Bid0.1050 x 0
Ask0.1100 x 0
Day's Range0.1000 - 0.1100
52 Week Range0.0850 - 0.6000
Volume699,544
Avg. Volume1,760,083
Market Cap40.517M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1470
Earnings DateMay 10, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Halo Announces Closing of Los Angeles Dispensary Project Acquisition & Passage of Los Angeles Ordinance to Accelerate Approval of Winning Applicants
      Business Wire

      Halo Announces Closing of Los Angeles Dispensary Project Acquisition & Passage of Los Angeles Ordinance to Accelerate Approval of Winning Applicants

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to its press releases dated January 16, March 2, 2020, March 6, 2020, and March 31, 2020 it has closed the following acquisitions:

    • Halo Announces Extension of the Binding LOI with Canmart Limited And Provides Update on Positive UK Market Developments
      Business Wire

      Halo Announces Extension of the Binding LOI with Canmart Limited And Provides Update on Positive UK Market Developments

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) announces that further to the press releases dated December 24, 2019 and March 3, 2020, and April 27, 2020, the Company has agreed to another extension of the binding letter of intent (the "LOI") to acquire all of the common shares of Canmart Limited ("Canmart"), a licensed importer and distributor of cannabis based products for medicinal use ("CBPM’s"). Due to the ongoing global COVID-19 pandemic, the Company has agreed to the extension to allow both parties adequate time to complete due diligence and negotiate the definitive agreements while under shelter-in-place restrictions. While the extension grants until August 21, 2020 to finalize, the Company anticipates signing the final SPA and closing the transaction on or about July 15, 2020.

    • Halo Labs Corrects Press Release Relating to Issuance of Compensation Shares and Compensation Warrants to Independent Consultants and Related Parties
      Business Wire

      Halo Labs Corrects Press Release Relating to Issuance of Compensation Shares and Compensation Warrants to Independent Consultants and Related Parties

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) wishes to correct the Company’s press release dated June 20, 2020 (the "Initial Release") with respect to the issuance of 12,043,924 common shares of the Company to certain independent consultants and related parties of the Company, in lieu of cash consideration (the "Compensation Shares") at a price of C$0.10 per Compensation Share, being the closing price of the common shares of the Company on May 26, 2020, and the issuance of 1,000,000 warrants ("Compensation Warrants") with an exercise price of $0.10 and an expiry date that is one year from the date of issuance to an independent consultant (collectively, the "Issuance").

    • Halo Labs Announced Edibles Expansion in California and Oregon
      Business Wire

      Halo Labs Announced Edibles Expansion in California and Oregon

      Halo Labs is pleased to announce an update on the Company’s edibles product launch and expansion plan in California and Oregon to capitalize on segment growth. According to BDS Analytics, edibles spending in the US and Canada is forecast to grow to more than $4.1 billion by 2022. In California, ingestibles generated $44 million in sales in April 2020, 3 percent growth when compared to April 2019. In Oregon, ingestibles generated $12.5 million in sales in April 2020 and represents 18 percent growth from April 2019.

    • Business Wire

      Halo Announces Corporate Update Conference Call on June 24th

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces that it will host a conference call on Wednesday, June 24, 2020 to discuss Q1 2020 financial and operational results.

    • Halo Labs Reports Financial Results for First Quarter 2020
      Business Wire

      Halo Labs Reports Financial Results for First Quarter 2020

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced its financial and operational results for the three months ended March 31, 2020. Revenue for the three months ended March 31, 2020 were $4,449,098, a 49% decrease compared to $8,718,503 in the three months ended March 31, 2019. Revenues were comprised of $3,963,509 from ANM, Inc. ("ANM") (three months ended March 31, 2019: $2,879,769), $111,263 from HLO Ventures (NV), LLC ("HLO") (three months ended March 31, 2019: $511,096), $103,949 from Coastal Harvest LLC ("Coastal Harvest") (three months ended March 31, 2019: $5,327,638) and $428,760 from Mendo Distribution and Transportation LLC ("MDT") which was acquired January 9, 20201.

    • Halo Labs Completes Issuance of Shares to Independent Consultants, Related Parties and Suppliers
      Business Wire

      Halo Labs Completes Issuance of Shares to Independent Consultants, Related Parties and Suppliers

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced the issuance of 12,043,924 common shares of the Company to certain independent consultants, related parties, and suppliers of the Company, in lieu of cash consideration (the "Compensation Shares") at a price of C$0.10 per Compensation Share, being the closing price of the common shares of the Company on May 26, 2020.

    • East Evans Creek Farm Update Flower, Pre-Roll & Clone Oregon Business Overview
      Business Wire

      East Evans Creek Farm Update Flower, Pre-Roll & Clone Oregon Business Overview

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce overall improvement in Oregon’s flower category and flower product related sales. According to BDS Analytics, category sales of flower and pre-rolls have grown at 51% and 56% for the first four months of calendar year 2020 when compared to the same four month period in 2019.

    • Halo Enters Into Amended and Restated Convertible Promissory Note for Aggregate Principal Amount of up to C$10 Million
      Business Wire

      Halo Enters Into Amended and Restated Convertible Promissory Note for Aggregate Principal Amount of up to C$10 Million

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces that the Company has entered into an amended and restated promissory note (the "A&R Promissory Note") for a principal amount of up to $10 million.

    • REPEAT/Halo Labs Provides California Update
      Business Wire

      REPEAT/Halo Labs Provides California Update

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that retail sales of the Company’s Hush™ branded products have been have been growing in the state of California. In addition progress has been made on other initiatives in California.

    • Halo Labs Provides California Update
      Business Wire

      Halo Labs Provides California Update

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that retail sales of the Company’s Hush™ branded products have been have been growing in the state of California. In addition progress has been made on other initiatives in California.

    • REPEAT/Halo Labs Announces Partnership with Zkittlez™ Providing Award Winning Genetics in Oregon
      Business Wire

      REPEAT/Halo Labs Announces Partnership with Zkittlez™ Providing Award Winning Genetics in Oregon

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has entered into an exclusive strategic partnership with Terphogz™, LLC ("Zkittlez™") to develop and commercialize new and unique cannabis genetics in Oregon.

    • Halo Labs Announces Partnership with Zkittlez™ Providing Award Winning Genetics in Oregon
      Business Wire

      Halo Labs Announces Partnership with Zkittlez™ Providing Award Winning Genetics in Oregon

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has entered into an exclusive strategic partnership with Terphogz™, LLC ("Zkittlez™") to develop and commercialize new and unique cannabis genetics in Oregon.

    • Halo Labs Provides Oregon Sales Update
      Business Wire

      Halo Labs Provides Oregon Sales Update

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that retail sales of the Company’s Hush™ branded products have been growing in the state of Oregon.

    • Halo to Postpone Reporting Interim Financial Results Due to Delays Caused by the COVID-19 Pandemic
      Business Wire

      Halo to Postpone Reporting Interim Financial Results Due to Delays Caused by the COVID-19 Pandemic

      Halo Labs Inc. ("Halo" or the "Company") (NEO:HALO, OTCQX:AGEEF, Germany:A9KN) today announces that, due to delays caused by the COVID-19 pandemic, it is relying on the exemption provided in Ontario Instrument 51-502 - Temporary Exemption from Certain Corporate Finance Requirements (the "Instrument") of the Ontario Securities Commission (and similar exemptions provided by other Canadian securities regulators) to postpone the filing of the following continuous disclosure documents (collectively, the "Disclosure Documents"):

    • Halo Labs to Present at Canaccord Genuity’s Cannabis Virtual Conference on May 12th
      Business Wire

      Halo Labs to Present at Canaccord Genuity’s Cannabis Virtual Conference on May 12th

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that Halo Labs’ CEO Kiran Sidhu will be presenting at the 4th Annual Global Cannabis Virtual Conference hosted by Canaccord Genuity on May 12th, 2020 at 12:40pm to 1pm (EDT).

    • REPEAT/Halo Provides Operational Update
      Business Wire

      REPEAT/Halo Provides Operational Update

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to provide shareholders with an operational update in the context of the ongoing Coronavirus (COVID-19) pandemic as the Company continues to grow dispensary sales revenues in these challenging conditions.

    • Halo Provides Operational Update
      Business Wire

      Halo Provides Operational Update

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to provide shareholders with an operational update in the context of the ongoing Coronavirus (COVID-19) pandemic as the Company continues to grow dispensary sales revenues in these challenging conditions.

    • Halo Labs Completes Issuance of Shares to Independent Consultants and Supplier
      Business Wire

      Halo Labs Completes Issuance of Shares to Independent Consultants and Supplier

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced the issuance of 10,860,213 common shares of the Company to certain independent consultants of the Company and a supplier of the Company, in lieu of cash consideration (the "Compensation Shares") at a price of C$0.115 per Compensation Share, being the closing price of the common shares of the Company on April 3, 2020.

    • Halo Labs Announces First Sale of Distillate From Superfiltration
      Business Wire

      Halo Labs Announces First Sale of Distillate From Superfiltration

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company made its first sale of distillate that was cleaned using the Company’s proprietary Superfiltration pilot program at Coastal Harvest in Cathedral City, California. Halo Labs intends to scale this process up to one hundred liters per week, which triples current capacity.

    • Halo Announces Proposed Partnership with FlowerShop* and G-Eazy
      Business Wire

      Halo Announces Proposed Partnership with FlowerShop* and G-Eazy

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) and FlowerShop* are excited to announce a new partnership that will bring much-needed employment opportunities to communities during the uncertain times of the COVID-19 global crisis. Halo intends to acquire a membership interest in FlowerShop*, in which G-Eazy is a partner and key member of the company.

    • Halo Announces Closing of the Previously Announced Private Placement For CAD $425,000 and Completion of Acquisition of Nasalbinoid Natural Devices Corp.
      Business Wire

      Halo Announces Closing of the Previously Announced Private Placement For CAD $425,000 and Completion of Acquisition of Nasalbinoid Natural Devices Corp.

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce, further to the press release dated April 6, 2020, it has completed the acquisition of all of the common shares of Nasalbinoid Natural Devices Corp. ("Nasalbinoid"). The Company, through its wholly-owned subsidiary, 1245316 B.C. Ltd. ("Subco") acquired all of the issued and outstanding shares in the capital of Nasalbinoid in exchange for 34,000,000 common shares of the Company at a deemed price of CAD $0.15 per share, by way of a three-cornered amalgamation under the Business Corporations Act (British Columbia) (the "Acquisition") as described and pursuant to an acquisition agreement dated April 3, 2020 among the Company, Subco, Nasalbinoid, and the shareholder of Nasalbinoid (the "Acquisition Agreement"). Pursuant to the Acquisition Agreement, Subco amalgamated with Nasalbinoid and formed "Halo Nasalbinoid Natural Devices Corp." in accordance with the provisions of the Business Corporations Act (British Columbia) and upon the terms and conditions set out in the amalgamation agreement dated April 3, 2020 between the Company, Subco and Nasalbinoid.

    • Halo Announces Corporate Update Conference Call on April 20th
      Business Wire

      Halo Announces Corporate Update Conference Call on April 20th

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce it will be hosting a conference call on Monday April 20th at 4:15 p.m. EST to provide investors with a current corporate update including a review and discussion of 2019 financial and operational results.

    • Halo Labs Reports Financial Results for Fourth Quarter and Year End December 31, 2019
      Business Wire

      Halo Labs Reports Financial Results for Fourth Quarter and Year End December 31, 2019

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced its 2019 financial and operational results. The Company reported revenues of $28.1 million for the year ended December 31, 2019, a 158% increase in comparison with the previous year. Adjusted gross profit was $5.3 million, excluding fair value gains in biological assets, impairment of inventory and non-reoccurring costs due to market circumstances in the fourth quarter in 2019. The adjusted gross margin in 2019 was 19% in comparison with -1% in 2018. Complete results are reported in the Company’s consolidated financial statements for the year ended December 31, 2019 and associated management discussion and analysis (the "MD&A").

    • Halo Labs Announces the Start of the Superfiltration Program in Cathedral City
      Business Wire

      Halo Labs Announces the Start of the Superfiltration Program in Cathedral City

      Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has started a pilot superfiltration program of live resin, fats and waxes, tails, terpenes and low grade distillate at Halo’s Coastal Harvest facility in Cathedral City, California. Halo has specialized expertise in cannabis extraction and follows internal guidelines that are more stringent than the state guidelines for levels of pesticides in cannabis products. Due to these policies in California alone, the Company has segregated approximately one million three hundred and fifty thousand grams of product that was written off as waste product (the "Waste Product").